Skip to main content

Table 2 APO E - CI - CII haplotype distribution in CAD and control subjects.

From: Apolipoprotein gene polymorphisms and plasma levels in healthy Tunisians and patients with coronary artery disease

Haplotype Control CAD
E2 - H1 - A1 0.0107 -
E2 - H1 - A2 - -
E2 - H2 - A1 0.0342 0.0191
E2 - H2 - A2 - 0.0183
E3 - H1 - A1 0.4155 0.4107
E3 - H1 - A2 0.4216 0.4446
E3 - H2 - A1 0.0167 0.0196
E3 - H2 - A2 0.0160 -
E4 - H1 - A1 0.0596 0.03836
E4 - H1 - A2 0.0072 -
E4 - H2 - A1 0.0180 0.0247
E4 - H2 - A2 - 0.0244
P 0.922  
  1. P: Probability values for the comparison of haplotype frequencies between controls and CAD.